Antiviral Therapy 13:
|
|
- Blaise Greer
- 5 years ago
- Views:
Transcription
1 Antiviral Therapy 13: Short communication Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients Stefan Mauss 1 *, Florian Berger 1, Dieter Kuschak 2, Julia Henke 1, Petra Hegener 1, Eva Wolf 3, Stephan Schauseil 2 and Guenther Schmutz 1 1 Center for HIV and Hepatogastroenterology, Duesseldorf, Germany 2 Medical Laboratories Duesseldorf, Duesseldorf, Germany 3 MUC-Research, Munich, Germany *Corresponding author: stefan.mauss@center-duesseldorf.de Background: Broad use of tenofovir and an ageing HIVinfected population have created an interest in renal function in HIV patients. Serum cystatin C is a newer marker of renal function and might be more sensitive than creatinine. Methods: Patients were enrolled consecutively in an observational study. HIV-seropositive patients naive to antiretroviral therapy (n=261) were compared with healthy volunteers undergoing check-up procedures (n=193). Estimated glomerular filtration rate (egfr) was derived using creatinine-based Modification of Diet in Renal Disease (MDRD) and Cockcroft Gault formulas or cystatin C-based calculations. HIV-seropositive patients starting antiretroviral therapy (n=92) were followed prospectively after enrolment. Results: MDRD showed a higher median egfr in antiretroviral- naive HIV-seropositive patients compared with controls (104 versus 93 ml/min; P<0.001). Cockcroft Gault gave similar results (118 versus 106 ml/min; P<0.001). By contrast, cystatin C levels in HIV-seropositive individuals were higher, resulting in a lower median egfr compared with controls (99 versus 120 ml/min; P<0.001). Cystatin C was positively correlated with HIV RNA (r=0.33, P<0.01) and inversely correlated with CD4 + T-cell count (r=-0.29, P<0.01). Initiating antiretroviral therapy (n=92) decreased cystatin C levels and led to an increased cystatin C-based egfr from median 84 to 103 ml/min at week 24 (P<0.001). Serum creatinine was not substantially altered. Conclusions: Correlation of cystatin C with HIV RNA and CD4 + T cell count, plus decrease of cystatin C after suppression of HIV replication, suggest an increase of cystatin C levels by active HIV infection. This might result in overestimation of renal impairment, particularly in treatment-naive patients. Therefore, use of cystatin C to calculate GFR in HIV-seropositive individuals should not be recommended without further validation. Introduction There is an increasing need to assess renal function because of ageing among the HIV-infected population and the presence of potentially nephrotoxic antiretrovirals [1]. Formulas that provide estimated glomerular filtration rate (egfr) based on serum creatinine are well established, but might underestimate mild to moderate impairment of renal function [2]. In addition, creatinine-based formulas have not been specifically validated in HIV-seropositive populations. Recently, serum cystatin C has been reported to be a more sensitive marker of modest renal impairment [3,4]. Cystatin C is a non-glycosylated, low molecular weight (13 kda), basic protein produced by most nucleated cells. Cystatin C is freely filtered at the glomerulus and its production rate seems to be remarkably constant; therefore, its serum concentration has been proposed as a marker of GFR [5 8]. However, the use of cystatin C has not been systematically validated in HIV-infected individuals. Methods HIV-seropositive, treatment-naive, Caucasian patients were consecutively enrolled in a single centre. Healthy Caucasian individuals undergoing routine check-up procedures served as controls. The first cross-sectional 2008 International Medical Press
2 S Mauss et al. This pdf is for personal use only. To obtain commercial reprints, Table 1. Baseline data of HIV-seropositive antiretroviral therapy-naive patients and healthy controls Variable HIV-seropositive Control P-value Total, n Male gender, n (%) 226 (86) 90 (47) <0.001 BMI, kg/m ( ) 23.9 ( ) Age, years 37 (20 70) 46 (18 85) <0.001 Creatinine, mg/dl 0.85 ( ) 0.83 ( ) Cystatin C, mg/l 0.81 ( ) 0.70 ( ) <0.001 egfr MDRD, ml/min 104 (63 196) 93 (56 161) <0.001 egfr CG, ml/min 118 (61 330) 106 (52 211) <0.001 egfr cystatin, ml/min 99 (39 194) 120 (43 194) <0.001 Data shown are median (range) unless otherwise indicated. The Mann Whitney U test was used. BMI, body mass index; CG, Cockcroft Gault; egfr, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease. data set from HIV-seropositive patients and healthy controls was used for a comparison of cystatin C, creatinine levels and their respective egfrs. In the second data set, all patients starting antiretroviral therapy from April 2004 to August 2007 with a follow-up 24 weeks were longitudinally evaluated for the effect of antiretroviral therapy on egfr (n=92). Serum creatinine and cystatin C were analysed as part of the clinical routine from the same blood sample. Creatinine was measured on a Roche Modular P model (Roche, Mannheim, Germany) using a kinetic Jaffe test based on the Jaffe reaction, as modified by Bartels et al. [9]. Cystatin C was determined by particle-enhanced nephelometric immunoassays on a ProSpec machine (Dade Behring, Siemens Medical Solutions, Eschborn, Germany). A range of mg/l was covered with a detection limit for N latex cystatin C of 0.05 mg/l [10]. The dimension of egfr is given in ml/min with the understanding that these values are normalized to an average body surface area of 1.73 m 2. Formulas used for egfr by serum creatinine included the abbreviated Modification of Diet in Renal Disease (MDRD) formula (egfr MDRD [ml/min]=186 serum creatinine [mg/dl] exp age [years] exp ; if female) [11,12] and the Cockcroft Gault equation (egfr Cockcroft Gault [ml/min]=140- age [years] weight [kg]/72 serum creatinine [mg/dl]; 0.85 if female) [13]. The serum cystatin C-based equation was egfr cystatin C [ml/min]=74.835/(cystatin C [mg/l] exp 1.333) for the commercially available N latex cystatin C test used. For statistical analyses Mann Whitney U, Wilcoxon signed-rank, Spearman s rank and Friedman tests were used (SPSS GmbH version 15.0; SPSS, Munich, Germany). In logistic regression analyses, sex, age, HIV status and body mass index (BMI) were used as independent variables. Cystatin C, creatinine and their respective egfrs were outcome variables. The effect of each single variable was assessed after adjusting for the other three variables (StatView version 5.01; SAS Institute Inc., Cary, NC, USA). Results In total, 261 HIV-seroposititive treatment-naive individuals and 193 healthy controls were consecutively enrolled. Controls were older, had a higher BMI and were mostly female (Table 1). Compared with controls, the distribution of serum cystatin C levels showed a shift towards higher levels in HIV-seropositive patients compared with healthy controls (P<0.001; Table 1). In univariate analyses, both the MDRD and Cockcroft Gault formulas showed a higher median egfr in HIV-seropositive individuals compared with controls. By contrast, egfr based on cystatin C showed a significantly lower median egfr in HIV-seropositive individuals compared with controls (Table 1). In logistic regression analyses, sex, age, BMI and HIV status were entered as independent variables. After adjustment for the other three variables, the regression model showed a trend towards an association between HIV seropositivity with lower serum creatinine (odds ratio [OR] 0.56, 95% confidence interval [CI] , P=0.07) and a higher likelihood of a normal egfr as calculated by MDRD (OR 1.71, 95% CI , P=0.09) or Cockcroft Gault (OR 1.83, 95% CI , P=0.06). For cystatin C, the same logistic regression model showed that being HIV-seropositive (OR 3.66, 95% CI , P<0.0001) and being older (OR 2.26, 95% CI , P<0.0001) were significantly associated with higher cystatin C serum levels. As a result, being HIV-seropositive (OR 0.28, 95% CI , P<0.0001) or being older (OR 0.30, 95% CI , P<0.0001) were associated with an increased risk of a reduced egfr based on cystatin C International Medical Press
3 Cystatin C, renal function and HIV Cystatin C serum levels showed a positive correlation with higher HIV RNA (r=0.33, P<0.01) and an inverse correlation with CD4 + T-cell count (r=-0.29, P<0.01; Figure 1). In patients starting antiretroviral therapy (n=92), creatinine at baseline increased slightly from 0.85 to 0.89 mg/ dl at week 48 (P<0.001; Table 2). egfr calculated by MDRD decreased from 104 to 96 ml/min (P<0.001). Using Cockcroft Gault, egfr showed similar results (Table 2). In the same patients, baseline cystatin C serum levels decreased from median 0.92 to 0.77 mg/l at week 48 (P<0.001). Cystatin C-based egfr increased from 84 to 106 ml/min (P<0.001; Table 2). According to the MDRD formula, 23% of HIVseropositive individuals were classified as having renal insufficiency stage 2 (egfr ml/min) and none were in stage 3 (egfr ml/min), stage 4 (egfr ml/min) or stage 5 (egfr<14 ml/min) [14]. Among controls, stage 2 was observed in 45% of patients, stage 3 in 1% and stages 4 or 5 in none. A different pattern was observed using cystatin C, such that 36% of HIV-seropositive patients showed renal insufficiency stage 2, 5% showed stage 3 and none showed stages 4 or 5. In controls, stage 2 was observed in 10% of patients, stage 3 in 1% and stages 4 or 5 in none. The use of tenofovir had no effect on these findings. With MDRD, egfr decreased by 5 ml/min (range ml/min) in patients on tenofovir and by 3 ml/min (range ) in patients not on tenofovir (P=0.23). Using the Cockcroft Gault equation, egfr decreased by 5 ml/min (range ) in patients on tenofovir and by 3 ml/min (range ) in patients not on tenofovir (P=0.27). Patients with tenofovir (n=77) showed a median increase of cystatin C-based egfr of 15 ml/ min (range ) after 24 weeks of therapy compared with an increase of 23 ml/min (range ) in patients not treated with tenofovir (n=15, P=0.24). Discussion Among HIV-seropositive patients in this cross- sectional analysis, renal function assessed by formulas based on creatinine was markedly better than that estimated by cystatin C. This has been previously reported by four different papers, including one from our own group [4,15 17]. In all four publications, the possibility of underestimating renal impairment by using creatinine-based formulas compared with cystatin C was discussed. In the paper by Jaroszewicz et al. [16], cystatin C serum levels correlated positively with the level of HIV RNA. Odden et al. [4] reported an inverse correlation with the number of CD4 + T-cells [4]. In the present paper, we can confirm both observations. However, Figure 1. Association of cystatin C with HIV RNA or CD4 + T-cell count A Cystatin C, mg/l B Cystatin C, mg/l Spearman s ρ=0.329, P<0.01, n= HIV RNA, log 10 copies/ml Spearman s ρ=-0.287, P<0.01, n= ,200 1,400 CD4 + T-cell count, cells/µl Correlation between (A) serum cystatin C and HIV RNA and (B) serum cystatin C and CD4 + T-cell count in 261 HIV-seropositive patients naive to antiretroviral therapy. because of the cross-sectional nature of the previous studies the effect of HIV replication on cystatin C serum levels could not be separated from the effect of HIV and antiretroviral therapy on renal function. For this study, we included a longitudinal arm assessing the effect of antiretroviral therapy in previously untreated individuals on markers of renal function. Initiating antiretroviral therapy decreased serum cystatin C levels substantially, whereas serum creatinine levels were slightly increased. From our perspective, this suggests an interaction between HIV infection and cystatin C serum levels. Cystatin C is a cysteine protease inhibitor, for which serum levels have been shown to be altered by immunomodulating drugs such as prednisolone or cyclosporine A [18]. In addition, cystatin C level correlates with inflammation markers, such as C-reactive protein [19,20]. The positive correlation of cystatin C levels with HIV RNA and the inverse correlation with CD4 + T-cell count do suggest an increase of cystatin C Antiviral Therapy
4 S Mauss et al. This pdf is for personal use only. To obtain commercial reprints, Table 2. Effect of initiating antiretroviral therapy on serum creatinine, cystatin C and the respective calculated glomerular filtration rate Variable Baseline Week 12 Week 24 Week 48 Total, n Creatinine, mg/dl 0.85 ( ) 0.89 ( )* 0.89 ( )* 0.89 ( )* Cystatin C, mg/l 0.92 ( ) 0.84 ( )* 0.79 ( )* 0.77 ( )* egfr MDRD, ml/min 104 (68 180) 97 (69 149)* 99 (54 152)* 96 (64 135)* egfr CG, ml/min 117 (63 181) 110 (56 201)* 106 (63 183)* 108 (55 175)* egfr cystatin C, ml/min 84 (39 194) 96 (45 155)* 103 (52 179)* 106 (56 246)* HIV RNA<40 copies/ml, n (%) 0 (0) 52 (46) 76 (83) 70 (90) CD4 + T-cells, cells/µl 255 (17 833) 418 (81 1,445) 457 (93 1,445) 494 (161 1,406) Data shown are median (range) unless otherwise indicated. *P< CG, Cockcroft Gault; egfr, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease. by replicative HIV infection. This is further indicated by the decrease of cystatin C after suppression of HIV replication under antiretroviral therapy. Excluding or including tenofovir in the analysis did not change the findings. The data on the effect of tenofovir on renal function are conflicting, mostly showing little to modest changes of egfr, probably because of impairment of tubular function [21 23]. In conclusion, using cystatin C-based calculations of renal function might result in an overestimation of renal impairment, particularly in therapy-naive HIVseropositive patients. In patients with fully suppressed HIV replication, cystatin C levels are lower and could more accurately reflect renal function. This observation on cystatin C strongly suggests that new diagnostic markers, in particular markers associated with the immune system, have to be specifically validated for the use in HIV-seropositive patients. Transferring the use of those markers from studies in the general population without any further validation might lead to biased results. Disclosure statement The authors declare no competing interests. References 1. Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: Odden MC, Scherzer R, Bacchetti P, et al. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection. Arch Intern Med 2007; 167: Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001; 39: Grubb A, Nyman U, Björk J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan Barratt prediction equations for children. Clin Chem 2005; 51: Westhuyzen J. Cystatin C: a promising marker and predictor of impaired renal function. Ann Clin Lab Sci 2006; 36: Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: Bartels H, Böhmer M, Heierli C. Serum creatinine determination without protein precipitation. Clin Chim Acta 1972; 37: Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985; 45: Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000; 11:Abstract A Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS 2005; 19: Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration. Antivir Ther 2006; 11: Jones CY, Jones CA, Wilson IB, et al. Cystatin C and creatinine in an HIV cohort: The nutrition for healthy living study. Am J Kidney Dis 2008; 51: Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000; 300: Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007; 22: International Medical Press
5 Cystatin C, renal function and HIV 20. Samouilidou EC, Grapsa E. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis. Ren Fail 2008; 30: Fux CA, Simcock M, Wolbers M, et al. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther 2007; 12: Cassetti I, Madruga JV, Suleiman JM, et al. The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1- infected patients. HIV Clin Trials 2007; 8: Nelson MR, Katlama C, Montaner JS, et al. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS 2007; 21: Accepted for publication 14 September 2008 Antiviral Therapy
ORIGINAL ARTICLE Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries
(2012) 50, 778 783 & 2012 International Society All rights reserved 1362-4393/12 www.nature.com/sc ORIGINAL ARTICLE Estimating the glomerular filtration rate using serum cystatin C levels in patients with
More informationCystatin C-based Formula is Superior to MDRD, Cockcroft-Gault and Nankivell Formulae in Estimating the Glomerular Filtration Rate in Renal Allografts
Cystatin C-based Formula is Superior to MDRD, Cockcroft-Gault and Nankivell Formulae in Estimating the Glomerular Filtration Rate in Renal Allografts Ammar Qutb, 1 Ghulam Syed, 2 Hani M. Tamim, 3 Mohammad
More informationInternational Journal of Pharma and Bio Sciences IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS?
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE BIO CHEMISTRY IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS? Corresponding Author R.KUMARESAN Department
More informationIs the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?
Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration
More informationResearch Article Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography
Advances in Nephrology, Article ID 510209, 6 pages http://dx.doi.org/10.1155/2014/510209 Research Article Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography
More informationEffect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Effect of polymerase inhibitors on renal function in patients with chronic hepatitis B Stefan Mauss 1,, Florian Berger 1, Natalie Filmann, Dietrich Hueppe 3, Julia Henke 1, Petra Hegener 1, Christoph Athmann
More information9. GFR - WHERE ARE WE NOW?
How to Cite this article: GFR Where are We Now? - ejifcc 20/01 2009 http://www.ifcc.org 9. GFR - WHERE ARE WE NOW? Joris R. Delanghe 9.1 Abstract The availability of a worldwide standard for creatinine
More informationValidation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease
Kidney Diseases Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Osama El Minshawy, 1 Eman El-Bassuoni 2 Original Paper 1 Department
More informationA New Approach for Evaluating Renal Function and Its Practical Application
J Pharmacol Sci 105, 1 5 (2007) Journal of Pharmacological Sciences 2007 The Japanese Pharmacological Society Current Perspective A New Approach for Evaluating Renal Function and Its Practical Application
More informationCalculation of glomerular filtration rate based on Cystatin C in cirrhotic patients
Nephrol Dial Transplant (2006) 21: 660 664 doi:10.1093/ndt/gfi305 Advance Access publication 2 December 2005 Original Article Calculation of glomerular filtration rate based on Cystatin C in cirrhotic
More informationCan modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients?
Nephrol Dial Transplant (7) 22: 361 3615 doi:1.193/ndt/gfm282 Advance Access publication 22 September 7 Original Article Can modifications of the MDRD formula improve the estimation of glomerular filtration
More informationAcute renal failure Definition and detection
Acute renal failure Definition and detection Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM Definition Acute Renal Failure Acute Kidney Injury
More informationClinical Usefulness of Serum Cystatin C as a Marker of Renal Function
Original Article Complications Diabetes Metab J 214;38:278-284 http://dx.doi.org/1.493/dmj.214.38.4.278 pissn 2233-79 eissn 2233-87 DIABETES & METABOLISM JOURNAL Clinical Usefulness of Serum Cystatin C
More informationThe estimation of kidney function with different formulas in overall population
137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different
More informationCalculation of glomerular filtration rate based on Cystatin C in cirrhotic patients
NDT Advance Access published December 2, 2005 Nephrol Dial Transplant (2005) 1 of 5 doi:10.1093/ndt/gfi305 Original Article Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients
More informationDifferences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir (TDF)-treated Adults in ESS40006
13th Conference on Retroviruses and Opportunistic Infections Denver, CO, USA. February 5-9, 2006 Poster Number 777 Differences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir
More informationCystatin C-based calculation of glomerular filtration rate in kidney transplant recipients
http://www.kidney-international.org & 26 International Society of Nephrology Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients UPöge 1, T Gerhardt 1, B Stoffel-Wagner
More informationCystatin C: A New Approach to Improve Medication Dosing
Cystatin C: A New Approach to Improve Medication Dosing Erin Frazee Barreto, PharmD, MSc, FCCM Assistant Professor of Pharmacy and Medicine Kern Scholar, Center for the Science of Health Care Delivery
More informationShort communication Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration
Antiviral Therapy 11:641 645 Short communication Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration Jerzy Jaroszewicz, Alicja Wiercinska-Drapalo*,
More informationTenofovir plasma exposures and Creatinine Clearance changes in 1st line Regimen of African patients in Cameroon and Senegal: ANRS12115 DAYANA study
Abstract O_03 Tenofovir plasma exposures and Creatinine Clearance changes in 1st line Regimen of African patients in Cameroon and Senegal: ANRS12115 DAYANA study M.P. Lê Pharmacy Resident Clinical Pharmacology
More informationEvaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates
Clin Chem Lab Med 2005;43(9):953 957 2005 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2005.163 2005/147 Short Communication Evaluation of renal function in intensive care: plasma cystatin C
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationΕκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης
Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Ιατρική Σχολή ΑΠΘ Νοσοκομείο ΑΧΕΠA Θεσσαλομίκη Kidney in body homeostasis Excretory function Uremic toxins removal Vascular volume maintainance Fluid-electrolyte
More informationCharacteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests
Renal Tests Holly Kramer MD MPH Associate Professor of Public Health Sciences and Medicine Division of Nephrology and Hypertension Loyola University of Chicago Stritch School of Medicine Renal Tests 1.
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationThis is the author s version of a work that was submitted/accepted for publication in the following source:
This is the author s version of a work that was submitted/accepted for publication in the following source: Kelly, Mark D., Gibson, Abby, Bartlett, Harry, Rowling, Diane, & Patten, John (2013) Tenofovir-associated
More informationSerum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary -trace protein
Am J Physiol Renal Physiol 299: F1407 F1423, 2010. First published September 15, 2010; doi:10.1152/ajprenal.00507.2009. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients:
More informationScreening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!
Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationRenal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
Chua et al. AIDS Research and Therapy 2012, 9:19 SHORT REPORT Open Access Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort Arlene C Chua 1*, Ryan M Llorin 1, Kelvin Lai
More informationEnvironmental Variability
1 Environmental Variability Body Size, Body Composition, Maturation and Organ Function Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand the major sources
More informationUpdate on HIV-Related Kidney Diseases. Agenda
Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED
More informationRisk for chronic kidney disease increases with obesity: Health Survey for England 2010
Public Health Nutrition: 18(18), 3349 3354 doi:10.1017/s1368980015000488 Risk for chronic kidney disease increases with obesity: Health Survey for England 2010 Helen L MacLaughlin 1,2, *, Wendy L Hall
More informationOriginal Article. Saudi Journal of Kidney Diseases and Transplantation
Saudi J Kidney Dis Transpl 2014;25(5):1004-1010 2014 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Original Article Comparison of the Performance of the Updated,
More informationGlomerular filtration rate estimated by cystatin C among different clinical presentations
http://www.kidney-international.org & 2006 International Society of Nephrology Glomerular filtration rate estimated by cystatin C among different clinical presentations AD Rule 1,2, EJ Bergstralh 3, JM
More informationSeung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine
Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253
More informationCystatin C (serum, plasma, urine)
Cystatin C (serum, plasma, urine) 1 Name and description of analyte 1.1 Name of analyte Cystatin C (serum, plasma and urine) 1.2 Alternative names Cystatin 3, post-gamma-globulin, neuroendocrine basic
More informationGlomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC
Glomerular Filtration Rate Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate (GFR): Amount of blood that is filtered per unit time through glomeruli. It is a measure of the function of kidneys. The
More informationHIV Viremia and T-Cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C
HIV Viremia and T-Cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C Bhavna Bhasin 1, Bryan Lau 1,2, Mohamed G. Atta 1, Derek
More informationThe inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients
NDT Advance Access published June 8, 2009 Nephrol Dial Transplant (2009) 1 5 doi: 10.1093/ndt/gfp255 Original Article The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationAm J Nephrol 2013;38: DOI: /
American Journal of Nephrology Original Report: Patient-Oriented, Translational Research Received: June 14, 13 Accepted: August 11, 13 Published online: September 3, 13 Combined Serum Creatinine and Cystatin
More informationSerum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus
Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus C. Chew 1, P.W. Pemberton 2, A. Al-M. Husain 1,3, S. Haque 3,4,
More informationRecently, the National Kidney Foundation endorsed a
Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease Andrew D. Rule, MD; Timothy S. Larson, MD; Erik J. Bergstralh, MSc; Jeff M. Slezak,
More informationEarly risk stratification is essential in the management of
Cystatin C A Novel Predictor of Outcome in Suspected or Confirmed Non ST-Elevation Acute Coronary Syndrome Tomas Jernberg, MD, PhD; Bertil Lindahl, MD, PhD; Stefan James, MD, PhD; Anders Larsson, MD, PhD;
More informationComparison between a serum creatinineand a cystatin C-based glomerular filtration rate equation in patients receiving amphotericin B
Karimzadeh and Khalili DARU Journal of Pharmaceutical Sciences (2016) 24:16 DOI 10.1186/s40199-016-0149-6 SHORT COMMUNICATION Comparison between a serum creatinineand a cystatin C-based glomerular filtration
More informationBangladesh Journal of Medical Science Vol. 16 No. 02 April 17
Bangladesh Journal of Medical Science Vol. 16 No. 02 April 17 Original article: Comparison of Chronic Kidney Disease Epidemiology Collaboration Equations with Other Accepted Equations for Estimation of
More informationCYSTATIN C. An Improved Way To Screen For Chronic Kidney Disease INNOVATIONS IN CLINICAL DIAGNOSTICS
CYSTATIN C An Improved Way To Screen For Chronic Kidney Disease INNOVATIONS IN CLINICAL DIAGNOSTICS About Diazyme Diazyme Laboratories, Inc., an affiliate of General Atomics, is located in Poway, California.
More informationGlomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat
New Microbiologica, 41, 4, 256-261, 2018, ISN 1121-7138 FULL PAPER Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat Nadia
More informationGlomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?
Diabetologia (2011) 54:2987 2994 DOI 10.1007/s00125-011-2307-1 ARTICLE Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations? F. Iliadis & T.
More informationA Study on Estimated Glomerular Filtration Rate As A Predictor of Renal Dysfunction Among Adult Hiv Patients on Highly Active Antiretroviral Therapy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. IX (Oct. 2017), PP 28-34 www.iosrjournals.org A Study on Estimated Glomerular Filtration
More informationCystatin-C and inflammatory markers in the ambulatory elderly
The American Journal of Medicine (2005) 118, 1416.e25-1416.e31 CLINICAL RESEARCH STUDY Cystatin-C and inflammatory markers in the ambulatory elderly Michael G. Shlipak, MD, MPH, a Ronit Katz, PhD, b Mary
More informationThe relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan
Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki
More informationChapter Two Renal function measures in the adolescent NHANES population
0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you
More informationMeasurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE
Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?
More informationReal Life Experience of Dolutegravir and Lamivudine Dual Therapy As a Switching Regimen in HIVTR Cohort
Real Life Experience of Dolutegravir and Lamivudine Dual Therapy As a Switching Regimen in HIVTR Cohort Yagci-Caglayik D 1, Gokengin D 2, Inan A 3, Ozkan-Ozdemir H 4, Inan D 5, Akbulut A 6, Korten V 1,
More informationEvaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study
Original article: Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Mukesh Agarwal Assistant Professor, Department of General Medicine, Teerthanker Mahaveer Medical College & Research
More informationCitation: Sorkhi H, Raheleh Behzadi, Joghtaei N, et al. Glomerular filtration rate determination by
Original Article Caspian J Intern Med 2018; 9(3):290-295 DOI: 10.22088/cjim.9.3.290 Glomerular filtration rate determination by creatinine and cystatin-c in patients with acute pyelonephritis Hadi Sorkhi
More informationComparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:
More informationAGING KIDNEY IN HIV DISEASE
AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV
More informationImproved estimation of glomerular filtration rate (GFR) by comparison of egfr cystatin C. and egfr creatinine
Scinavian Journal of Clinical & Laboratory Investigation 2012; 72: 73 77 ORIGINAL ARTICLE Improved estimation of glomerular filtration rate (GFR by comparison of egfr cystatin C ANDERS GRUBB 1 ULF NYMAN
More informationTDF Renal Dysfunction
TDF Renal Dysfunction Sarala Naicker MBChB, FRCP, PhD Division of Nephrology Dept of Internal Medicine University of the Witwatersrand Johannesburg South Africa SA HIV Clinician Society Conference Cape
More informationRenal safety of tenofovir in HIV-infected patients who switch from stavudine or zidovudine to tenofovir
Original Article Vol. 29 No. 3 Renal safety of tenofovir:- Wiwattanathum P & Sungkanuparph S. 113 Renal safety of tenofovir in HIV-infected patients who switch from stavudine or zidovudine to tenofovir
More information1950 CID 2009:49 (15 December) HIV/AIDS. Received 17 April 2009; accepted 31 July 2009; electronically published 13 November 2009.
HIV/AIDS BRIEF REPORT Long-Term Evolution and Determinants of Renal Function in HIV-Infected Patients Who Began Receiving Combination Antiretroviral Therapy in 1997 1999, ANRS CO8 APROCO-COPILOTE Catherine
More informationCorrelation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population
Clinical Chemistry 44:6 1334 1338 (1998) General Clinical Chemistry Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population Douglas Stickle, 1 Barbara
More informationComparison of Estimated Glomerular Filtration Rate Using Different Analytes in Chronic Kidney Disease Patients
ORIGINAL ARTICLE Comparison of Estimated Glomerular Filtration Rate Using Different Analytes in Chronic Kidney Disease Patients Bhoi Bharat K. 1*, Maheshwari Amitkumar V. 2, Sadariya Bhavesh R. 3, Shaikh
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationSafety Profile of Viread and Truvada. Ian McGowan, MD PhD FRCP Cape Town MTN Regional Meeting September, 2008
Safety Profile of Viread and Truvada Ian McGowan, MD PhD FRCP Cape Town MTN Regional Meeting September, 2008 Overview Safety assessment in drug development Physiology 101 Renal Bone Liver Safety profile
More informationPlasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study
Kunimoto et al. Journal of Pharmaceutical Health Care and Sciences (2016) 2:22 DOI 10.1186/s40780-016-0056-5 RESEARCH ARTICLE Open Access Plasma tenofovir trough concentrations are associated with renal
More informationRenal function vs chemotherapy dosing
Renal function vs chemotherapy dosing Jenny Casanova Senior Clinical Pharmacist Repatriation General Hospital Daw Park 1 Methods of estimating renal function Cockcroft-Gault (1976) C-G using ideal vs actual
More informationCystatin C Den svenske erfaringen.
Cystatin C Den svenske erfaringen. Cystatin C some basic facts the new IFCC cystatin C calibrator assay harmonization between different companies cystatin C not just a new marker for renal function! the
More informationIs There a Chronic Kidney Disease Epidemic? Profile of Chronic Kidney Disease in an Urban Renal Camp in Southern India
Original Article Is There a Chronic Kidney Disease Epidemic? Profile of Chronic Kidney Disease in an Urban Renal Camp in Southern India Venkata Dakshinamurty Kaligotla, 1 Shyam Chirravoori, 2 Malati Tangirala,
More informationNowadays, many centers rely on estimating equations
Renal Function Equations before and after Living Kidney Donation: A Within-Individual Comparison of Performance at Different Levels of Renal Function Hilde Tent,* Mieneke Rook,* Lesley A. Stevens, Willem
More informationChan HLY, Chan CK, Hui AJ, et al. Tenofovir Disoproxil Fumarate in Chronic HBV Infected Patients with Normal ALT and High HBV DNA Levels
Online supplement to: Chan HLY, Chan CK, Hui AJ, et al. Tenofovir Disoproxil Fumarate in Chronic HBV Infected Patients with Normal ALT and High HBV DNA Levels Supplementary Figure 1. CONSORT disposition
More informationGFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease
Nephrol Dial Transplant (2005) 20: 2394 2401 doi:10.1093/ndt/gfi076 Advance Access publication 23 August 2005 Original Article GFR prediction using the MDRD and Cockcroft and Gault equations in patients
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationACCEPTED. Title Page: Full Title: Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-Infected Patients with Mild. to Moderate Renal Impairment
JAIDS Journal of Acquired Immune Deficiency Syndromes Publish Ahead of Print DOI: 10.1097/QAI.0000000000000476 Title Page: Full Title: Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-Infected
More informationCarboplatin Time to Drop the Curtain on the Dosing Debate
Carboplatin Time to Drop the Curtain on the Dosing Debate Jon Herrington, Pharm.D., BCPS, BCOP Judith Smith, Pharm.D., BCOP, CPHQ, FCCP, FISOPP Scott Soefje, Pharm.D., MBA, BCOP Heimberg J, et al. N Engl
More informationThe impact of albuminuria and cardiovascular risk factors on renal function Verhave, Jacoba Catharijne
University of Groningen The impact of albuminuria and cardiovascular risk factors on renal function Verhave, Jacoba Catharijne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationDefining risk factors associated with renal and cognitive dysfunction Joosten, Johanna Maria Helena
University of Groningen Defining risk factors associated with renal and cognitive dysfunction Joosten, Johanna Maria Helena IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationCOMPETING INTEREST OF FINANCIAL VALUE
BHIVA AUTUMN CONFERENCE 2012 Including CHIVA Parallel Sessions Dr Ian Williams University College London Medical School COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Ian Williams
More informationTitle:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda
Author's response to reviews Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda Authors: Pancras Odongo (odongopancras@gmail.com)
More informationThe impact of antiretroviral drugs on renal function
The impact of antiretroviral drugs on renal function Professor Bruce Hendry Renal Medicine King s College London King s College Hospital NHS Foundation Trust 1 DISCLOSURES: BRUCE HENDRY I have received
More informationBritish Columbia is the first
Michael D.D. McNeely, MD, FRCPC, FCACB The estimated glomerular filtration rate: Linchpin of the chronic kidney disease guidelines The standardized reporting of serum creatinine values by BC laboratories
More informationMeasurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE
Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?
More informationSerum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine
Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine S. O Riordan, E. Ouldred, S. Brice, S. H. D. Jackson & C. G. Swift Clinical Age Research Unit, Department
More informationAssessing Renal Function: What you Didn t Know You Didn t Know
Assessing Renal Function: What you Didn t Know You Didn t Know Presented By Tom Wadsworth PharmD, BCPS Associate Clinical Professor UAA/ISU Doctor of Pharmacy Program Idaho State University College of
More informationProteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral- Naive HIV-Infected Subjects
BRIEF REPORT Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral- Naive HIV-Infected Subjects Samir K. Gupta, 1 Lauren Komarow, 2 Roy M. Gulick, 4 Richard B. Pollard, 5 Gregory K.
More informationFrom the 1 Department of Transplantation, Mayo Clinic, Jacksonville, FL; 2 Baylor Regional Transplant Institute, Dallas, TX; 3 Division of
Estimation of Glomerular Filtration Rates Before and After Orthotopic Liver Transplantation: Evaluation of Current Equations Thomas A. Gonwa, 1 Linda Jennings, 2 Martin L. Mai, 1 Paul C. Stark, 3 Andrew
More informationSimilar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:941 946 Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B ROBERT G. GISH,* MARGARET D. CLARK, STEVE
More informationTHE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS
214 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(3):23-212 doi: 1.2478/rjdnmd-214-25 THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES
More informationTDF containing ART: Efficacy and Safety. Dr Lloyd B. Mulenga Adult Infectious Diseases Centre University Teaching Hospital Lusaka, Zambia
TDF containing ART: Efficacy and Safety Dr Lloyd B. Mulenga Adult Infectious Diseases Centre University Teaching Hospital Lusaka, Zambia 1 Indications Treatment of HIV-1 in combination with other antiretroviral
More informationCystatin C is not a better estimator of GFR than plasma creatinine in the general population
http://www.kidney-international.org & 2010 International Society of Nephrology Cystatin C is not a better estimator of GFR than plasma creatinine in the general population Bjørn O. Eriksen 1,2, Ulla D.
More informationRenal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology
Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics
More informationEstimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations
original article http://www.kidney-international.org & 9 International Society of Nephrology Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations
More informationNovedades en el tratamiento de la hepatitis B: noticias desde la EASL. Maria Buti Hospital Universitario Valle Hebrón Barcelona
Novedades en el tratamiento de la hepatitis B: noticias desde la EASL Maria Buti Hospital Universitario Valle Hebrón Barcelona Milestones in CHB treatment Conventional IFN 1991 Lamivudine (LAM) 1998 Adefovir
More informationOriginal article Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients
Antiviral Therapy 2013; 18:793 802 (doi: 10.3851/IMP2676) Original article Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients Aghogho A Okparavero 1, Hocine
More informationGlomerular Filtration Rate Estimations and Measurements. Pierre Delanaye, MD, PhD University of Liège CHU Sart Tilman BELGIUM
Glomerular Filtration Rate Estimations and Measurements Pierre Delanaye, MD, PhD University of Liège CHU Sart Tilman BELGIUM Summary Estimating GFR (creatinine, egfr, cystatin C) Measuring GFR Summary
More informationPage 1. Disclosures. Main Points of My Talk. Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance
1 Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance John Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Laboratories Professor of Pathology Duke University
More information